Health Professional Radio - Podcast

Cellectis has pioneered the "off-the-shelf" approach to gene editing CAR T-cells to treat cancer and other genetic diseases. Dr. André Choulika discusses how this approach allows treatments to be produced by the thousands from healthy donor cells (versus the patient's own cells), stored long-term, provided to hospitals around the world and given to any patient who is in medical need. Off-the-shelf gene editing marks the next transformative step in medicine, and Cellectis has the first U.S. clinical trials underway now.